Scientists drive detailed study into how cancer cells spread
With the help of the mouse model, scientists of Kanazawa University drove a detailed study to explain how the cells which are known to aid with the spread and progression of cancer commute in the body.
Most tumors consist of a heterogeneous mix of cells. Genetic mutations found only in some of these cells are known to aid with the spread and progression of cancer. However, oncologists often find that when tumors metastasize to distant organs, they retain this heterogeneous nature--a phenomenon termed "polyclonal metastasis".
The mechanism by which non-metastatic cells accompany the metastatic cells is ambiguous. Now, Masanobu Oshima and his research team have used mouse models to explain how non-metastatic cells begin their long commute.
The team has previously developed various cancerous mutants of mice and analyzed them closely to reveal which cancer cells inherently spread and which do not. It was found that cells with four mutations, colloquially termed AKTP, were the most fatal. When these cells were transplanted into the spleens of mice, they migrated to and formed colonies in the livers within 3 days.
In contrast, cells with two mutations, AK and AP, could not traverse this distance. To replicate polyclonal metastasis, AP cells were then co-transplanted with AKTP cells, and voila, both cell types indeed moved into the livers. Instead, when AP cells were injected into the blood (without prior exposure to the AKTP cells) they could not metastasize. Certain processes seemed to be at play when the cells were incubated together.
Next, AKTP cells within the liver tumors were killed to see how closely that affected the AP cells. The AP cells continued thriving and grew into larger tumors suggesting they did not need the AKTP cells anymore. Thus, at some point in the journey from the spleen to the liver, the AP cells turned dangerous.
To identify this point, the researchers traced back the chain of events. Within a day after transplantation, AKTP clusters were found in the sinusoid vessel, a major blood vessel supplying the liver. By 14 days, this cluster transformed into a mass termed as a "fibrotic niche". The same mass was observed with a mix of AP and AKTP cells, but not with AP cells alone.
What's more, within this mass AKTP cells were activating hepatic stellate cells (HSCs). HSCs are responsible for the scarring of liver tissue. Activated HSCs then set up the perfect environment for AP cells to proliferate infinitely. Harboring the AP cells within the fibrotic environment was, therefore, a key step.
"These results indicate that non-metastatic cells can metastasize via the polyclonal metastasis mechanism using the fibrotic niche induced by malignant cells," conclude the researchers. Targeting this fibrotic niche might be a promising strategy to keep the spread of solid tumors in check.
Also Read: COVID-19 virus can cause blood-brain barrier, says new study